India to Launch First Indigenous H5N1 Chicken Vaccine on Nov 20

Union Minister Shivraj Singh Chouhan will unveil the country's first indigenous H5N1 vaccine for poultry on November 20, 2026.

A
Aapla Nagpur Desk
18 Nov 2026, 11:25 AM IST · 2 min read
Source: Ddnews
India to Launch First Indigenous H5N1 Chicken Vaccine on Nov 20
KEY TAKEAWAYS
1

The vaccine targets the H5N1 Highly Pathogenic Avian Influenza virus.

2

Bird flu outbreaks have significant economic impacts on poultry farmers.

3

No commercial vaccine currently exists for the specific H5N1 strain in India.

On November 20, 2026, Union Agriculture and Farmers Welfare Minister Shivraj Singh Chouhan will inaugurate India's first indigenous inactivated H5N1 vaccine for chickens at the ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD) in Bhopal. This groundbreaking vaccine is designed to combat the H5N1 Highly Pathogenic Avian Influenza (HPAI) virus, specifically the Clade 2.3.2.1a strain, which poses a serious threat to poultry health in the country.

The HPAI, commonly referred to as bird flu, has been a significant concern for poultry farmers since it can lead to nearly total mortality in infected birds. The disease has been present in India since 2006, with over 500 outbreaks reported involving H5N1 and H5N8 subtypes. These outbreaks not only threaten the health of poultry but also have far-reaching economic consequences, including substantial financial losses due to culling and trade restrictions.

The economic implications of bird flu are severe, with estimates suggesting that a major outbreak could reduce India's GDP growth by as much as 1.5%. Additionally, more than 20% of the country's poultry population could be at risk if the virus spreads unchecked. The 2006 outbreak alone resulted in losses estimated between Rs 2,200-3,000 crore, highlighting the urgent need for effective vaccination strategies.

Beyond economic impacts, bird flu is also a public health issue. The World Health Organization (WHO) has reported over 1,000 human cases of H5N1 avian influenza globally since 2003, with a significant number of fatalities. The strain associated with Clade 2.3.2.1a has been responsible for most outbreaks in chickens and has also been detected in other animal species, raising concerns about zoonotic transmission.

The indigenous vaccine developed by ICAR-NIHSAD aims to fill the current gap in vaccination options against the H5N1 virus. With no commercial vaccine available for this specific strain, the introduction of this vaccine is expected to bolster poultry health, mitigate economic losses for farmers, and reduce the risk of virus transmission to humans and other animals. The launch on November 20 is anticipated to be a significant milestone in India's efforts to combat avian influenza.

💬What did you think of this story?What did you think?

Read Next

India's First Indigenous H5N1 Chicken Vaccine Launch